Righi L, Graziano P, Fornari A et al.
University of Turin, Turin, Italy.
Cancer 2011;117:3416–23.
Editor’s note: Fine needle aspiration (FNA) cytology samples from patients with lung cancer may pose a pathological challenge when it comes to subtyping the cancer. This is important now that chemotherapy and epidermal growth factor tyrosine kinase inhibitors are used in relation to tumor subtype and the presence of mutations.